Mick received his Ph.D. in pharmaceutics (Professor Eugene L. Parrott) from the University of Iowa in 1990. He then began working at Glaxo/Glaxo Wellcome/GlaxoSmithKline as a senior scientist. He worked in product development for 17 years and played a key role in the development of several commercial products including Wellbutrin SR 100 and 200 mg Tablets, Wellbutrin XL 150 and 300 mg Tablets, Epivir Oral Liquid, Zantac 25 mg Effervescent Tablets and Zantac Soft Gelatin Capsules. During this time he also served as an adjunct assistant professor in pharmaceutical sciences at Campbell University School of Pharmacy. He was named co-inventor on numerous patent applications, wrote several book chapters, published a number of papers, and presented numerous podium and poster presentations. Since 2008 he has been serving as Director of University of Iowa Pharmaceuticals, the College of Pharmacy’s cGMP service division. In addition to his responsibilities as Director of UI Pharmaceuticals, Mick is an associate professor of pharmaceutics.